Option chain shows key data for SCOR's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for SCOR.

SCOR (OTC:SCRYY) Stock, Option Chain

SCOR ADS

Scor is the world's sixth-largest reinsurer, selling nonlife and life reinsurance. Scor global life insures life insurance and annuities. This means in its co-insurance agreements Scor shares in premiums and claims of life insurance contracts that have been sold by a primary insurer. In its excess of loss agreements, Scor reimburses a primary insurer for claims that are filed above an agreed amount. Scor also sells property and casualty reinsurance in coinsurance and excess of loss. Historically, Scor has been better in specialist lines and not as good in lines where there is a large potential for loss. Having recently grown in natural catastrophe, standards of underwriting have not been good. The business has subsequently decided to move back to less volatile lines.

News

Intraday Update

Markets

Movers

Trading Ideas

AAEEF

AAVMY

ABEV

ABGSF

ABMD

ABTX

ACCFF

ACCYY

ACHV

ACNB

ACRFF

ACRGF

ACSAY

ACST

ACTG

ADMA

ADTN

ADVZF

AERI

AFLYY

AGCO

AGEEF

AGESY

AGLXY

AHFD

AHKSY

AHOTF

AICAF

AINV

AIPUY

AIRG

AIRYY

AISSF

AKO-A

AKZOY

ALDX

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ALEX

Allianz Ag Muenchen Namen-Akt Vinkuliert Shares

ALIZF

ALLY

ALOT

ALSN

ALTM

ALXEF

ALXN

AMCR

AMHPF

AMKBF

AMKBY

AMNB

AMPH

AMRN

AMSLF

ANAT

ANGO

ANIP

Australia and New Zealand Banking Group Limited

ANZBY

ANZFF

APELY

APEX

APHA

APTS

ARCB

ARCC

ARGGY

ARGO

ARLP

ARNA

ARNGF

AROC

ARREF

ARRRF

Stocks That Hit 52-Week Lows On Friday

ABCE

AMADF

AMCX

ANLDF

APVO

AQARF

ARCH

ASBRF

ASIX

ATRO

ATROB

ATUSF

AWCMY

AXION VENTURES INC by Axion Ventures Inc.

AXNVF

BBDO

BBSI

BCII

BFCH

BKUCF

BMMJ

BORR

BPAQF

BPMP

BRID

BRRAY

BUHPF

CANNABIS ONE HLDGS INC by Cannabis One Holdings Inc.

CAAOF

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CCDBF

CCLLF

CCLP

CDEV

CEQP

CHOOF

CHRRF

CJPRY

CJREF

CLDT

CLVLY

CNDT

CNXM

COKE

CRON

CWBHF

CWYUF

CYBL

DAKT

DCIX

DGEAF

DLNDY

DLTH

DNKLY

DRTT

EARS

EBIX

ECAOF

EMERALD HEALTH THERAPUTCS by Emerald Health Therapeutics Inc.

EMHTF

ENBL

ENLC

ENOB

FRONTERA ENERGY CORP ORD by Frontera Energy Corp

FECCF

FLNG

Stocks That Hit 52-Week Lows On Wednesday

SCOR SE

&nbsp;
<h2>Upgrades</h2>
<ul>
<li>For Consolidated Communications Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNSL#NASDAQ">CNSL</a>), Citigroup upgraded the previous rating of Sell to Neutral. Consolidated Comms Hldgs earned $0.09 in the second quarter, compared to $0.21 in the year-ago quarter. At the moment, the stock has a 52-week-high of $9.89 and a 52-week-low of $4.45. Consolidated Comms Hldgs closed at $7.69 at the end of the last trading period.</li>
<li>Barrington Research upgraded the previous rating for Dolby Laboratories Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) from Market Perform to Outperform. For the third quarter, Dolby Laboratories had an EPS of $0.71, compared to year-ago quarter EPS of $0.86. At the moment, the stock has a 52-week-high of $104.74 and a 52-week-low of $63.45. Dolby Laboratories closed at $97.10 at the end of the last trading period.</li>
<li>According to Citigroup, the prior rating for AllianceBernstein Holding LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AB#NYSE">AB</a>) was changed from Neutral to Buy. For the second quarter, AllianceBernstein Holding had an EPS of $0.91, compared to year-ago quarter EPS of $0.61. The stock has a 52-week-high of $48.83 and a 52-week-low of $26.33. At the end of the last trading period, AllianceBernstein Holding closed at $48.27.</li>
<li>Raymond James upgraded the previous rating for Encompass Health Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) from Outperform to Strong Buy. For the second quarter, Encompass Health had an EPS of $1.17, compared to year-ago quarter EPS of $0.31. The stock has a 52-week-high of $89.68 and a 52-week-low of $60.44. At the end of the last trading period, Encompass Health closed at $83.25.</li>
<li>According to Stephens &amp; Co., the prior rating for GreenSky Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSKY#NASDAQ">GSKY</a>) was changed from Underweight to Equal-Weight. For the second quarter, GreenSky had an EPS of $0.25, compared to year-ago quarter EPS of $0.06. At the moment, the stock has a 52-week-high of $7.40 and a 52-week-low of $3.34. GreenSky closed at $6.57 at the end of the last trading period.</li>
<li>Deutsche Bank upgraded the previous rating for Bloomin Brands Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLMN#NASDAQ">BLMN</a>) from Hold to Buy. In the second quarter, Bloomin Brands showed an EPS of $0.81, compared to $0.74 from the year-ago quarter. The current stock performance of Bloomin Brands shows a 52-week-high of $32.81 and a 52-week-low of $10.34. Moreover, at the end of the last trading period, the closing price was at $25.13.</li>
<li>For Balchem Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCPC#NASDAQ">BCPC</a>), HC Wainwright &amp; Co. upgraded the previous rating of to Buy. For the second quarter, Balchem had an EPS of $0.93, compared to year-ago quarter EPS of $0.85. At the moment, the stock has a 52-week-high of $139.59 and a 52-week-low of $92.60. Balchem closed at $134.89 at the end of the last trading period.</li>
<li>For Capri Holdings Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPRI#NYSE">CPRI</a>), MKM Partners upgraded the previous rating of Neutral to Buy. For the first quarter, Capri Holdings had an EPS of $1.42, compared to year-ago quarter EPS of $1.04. At the moment, the stock has a 52-week-high of $59.60 and a 52-week-low of $13.80. Capri Holdings closed at $56.31 at the end of the last trading period.</li>
<li>According to Susquehanna, the prior rating for First Solar Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSLR#NASDAQ">FSLR</a>) was changed from Neutral to Positive. In the second quarter, First Solar showed an EPS of $0.77, compared to $0.39 from the year-ago quarter. The stock has a 52-week-high of $112.50 and a 52-week-low of $58.34. At the end of the last trading period, First Solar closed at $86.04.</li>
<li>Evercore ISI Group upgraded the previous rating for Veoneer Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNE#NYSE">VNE</a>) from Underperform to In-Line. Veoneer earned $0.89 in the second quarter, compared to $0.80 in the year-ago quarter. The current stock performance of Veoneer shows a 52-week-high of $32.70 and a 52-week-low of $9.56. Moreover, at the end of the last trading period, the closing price was at $31.32.</li>
<li>For Infinity Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>), JP Morgan upgraded the previous rating of Neutral to Overweight. Infinity Pharmaceuticals earned $0.13 in the second quarter, compared to $0.16 in the year-ago quarter. The current stock performance of Infinity Pharmaceuticals shows a 52-week-high of $5.98 and a 52-week-low of $0.82. Moreover, at the end of the last trading period, the closing price was at $2.12.</li>
<li>According to Raymond James, the prior rating for LKQ Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKQ#NASDAQ">LKQ</a>) was changed from Market Perform to Outperform. LKQ earned $1.13 in the second quarter, compared to $0.53 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.99 and a 52-week-low of $26.73. LKQ closed at $50.75 at the end of the last trading period.</li>
<li>Piper Sandler upgraded the previous rating for Avantor Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVTR#NYSE">AVTR</a>) from Neutral to Overweight. Avantor earned $0.35 in the second quarter, compared to $0.19 in the year-ago quarter. The current stock performance of Avantor shows a 52-week-high of $38.04 and a 52-week-low of $20.27. Moreover, at the end of the last trading period, the closing price was at $37.58.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings upgrades.</a>
&nbsp;
<h2>Downgrades</h2>
<ul>
<li>For Lufax Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LU#NYSE">LU</a>), Goldman Sachs downgraded the previous rating of Buy to Neutral. Interestingly, in the first quarter, Lufax Holding&#39;s EPS was $0.30. The current stock performance of Lufax Holding shows a 52-week-high of $19.56 and a 52-week-low of $7.05. Moreover, at the end of the last trading period, the closing price was at $7.50.</li>
<li>For Teladoc Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>), Argus Research downgraded the previous rating of Buy to Hold. Teladoc Health earned $0.86 in the second quarter, compared to $0.34 in the year-ago quarter. The current stock performance of Teladoc Health shows a 52-week-high of $308.00 and a 52-week-low of $129.74. Moreover, at the end of the last trading period, the closing price was at $148.45.</li>
<li>Deutsche Bank downgraded the previous rating for The Estee Lauder Companies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) from Buy to Hold. Estee Lauder Cos earned $1.62 in the third quarter, compared to $0.86 in the year-ago quarter. At the moment, the stock has a 52-week-high of $336.56 and a 52-week-low of $187.75. Estee Lauder Cos closed at $333.83 at the end of the last trading period.</li>
<li>For Byline Bancorp Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BY#NYSE">BY</a>), Stephens &amp; Co. downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, Byline Bancorp had an EPS of $0.77, compared to year-ago quarter EPS of $0.24. The stock has a 52-week-high of $25.78 and a 52-week-low of $10.49. At the end of the last trading period, Byline Bancorp closed at $24.61.</li>
<li>For Balchem Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCPC#NASDAQ">BCPC</a>), Stephens &amp; Co. downgraded the previous rating of Overweight to Equal-Weight. For the second quarter, Balchem had an EPS of $0.93, compared to year-ago quarter EPS of $0.85. The current stock performance of Balchem shows a 52-week-high of $139.59 and a 52-week-low of $92.60. Moreover, at the end of the last trading period, the closing price was at $134.89.</li>
<li>Goldman Sachs downgraded the previous rating for Liberty Oilfield Services Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LBRT#NYSE">LBRT</a>) from Buy to Neutral. For the second quarter, Liberty Oilfield Services had an EPS of $0.31, compared to year-ago quarter EPS of $0.55. The stock has a 52-week-high of $17.78 and a 52-week-low of $5.47. At the end of the last trading period, Liberty Oilfield Services closed at $10.19.</li>
<li>William Blair downgraded the previous rating for AptarGroup Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATR#NYSE">ATR</a>) from Outperform to Market Perform. In the second quarter, AptarGroup showed an EPS of $0.91, compared to $0.80 from the year-ago quarter. At the moment, the stock has a 52-week-high of $158.97 and a 52-week-low of $110.34. AptarGroup closed at $128.92 at the end of the last trading period.</li>
<li>For ResMed Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RMD#NYSE">RMD</a>), Needham downgraded the previous rating of Buy to Hold. ResMed earned $1.30 in the third quarter, compared to $1.29 in the year-ago quarter. The current stock performance of ResMed shows a 52-week-high of $272.75 and a 52-week-low of $165.72. Moreover, at the end of the last trading period, the closing price was at $271.80.</li>
<li>For Misonix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSON#NASDAQ">MSON</a>), BTIG downgraded the previous rating of Buy to Neutral. For the third quarter, Misonix had an EPS of $0.22, compared to year-ago quarter EPS of $0.34. At the moment, the stock has a 52-week-high of $26.86 and a 52-week-low of $11.04. Misonix closed at $26.54 at the end of the last trading period.</li>
<li>For Telephone and Data Systems Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>), JP Morgan downgraded the previous rating of Neutral to Underweight. Telephone and Data earned $0.48 in the first quarter, compared to $0.59 in the year-ago quarter. At the moment, the stock has a 52-week-high of $26.51 and a 52-week-low of $16.38. Telephone and Data closed at $22.35 at the end of the last trading period.</li>
<li>Raymond James downgraded the previous rating for W.W. Grainger Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWW#NYSE">GWW</a>) from Outperform to Market Perform. In the second quarter, W.W. Grainger showed an EPS of $4.27, compared to $3.75 from the year-ago quarter. The stock has a 52-week-high of $479.87 and a 52-week-low of $333.10. At the end of the last trading period, W.W. Grainger closed at $444.58.</li>
<li>According to Keybanc, the prior rating for SciPlay Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPL#NASDAQ">SCPL</a>) was changed from Overweight to Sector Weight. SciPlay earned $0.21 in the first quarter, compared to $0.19 in the year-ago quarter. At the moment, the stock has a 52-week-high of $21.74 and a 52-week-low of $11.76. SciPlay closed at $16.09 at the end of the last trading period.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings downgrades.</a>
&nbsp;
<h2>Initiations</h2>
<ul>
<li>Craig-Hallum initiated coverage on Forma Therapeutics Holdings Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FMTX#NASDAQ">FMTX</a>) with a Buy rating. The price target for Forma Therapeutics Hldgs is set to $58.00. Interestingly, in the first quarter, Forma Therapeutics Hldgs&#39;s EPS was $0.76. At the moment, the stock has a 52-week-high of $56.33 and a 52-week-low of $21.10. Forma Therapeutics Hldgs closed at $22.89 at the end of the last trading period.</li>
<li>Macquarie initiated coverage on Rush Street Interactive Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RSI#NYSE">RSI</a>) with an Outperform rating. The price target for Rush Street Interactive is set to $21.00. In the first quarter, Rush Street Interactive earned $0.08. The stock has a 52-week-high of $26.55 and a 52-week-low of $9.47. At the end of the last trading period, Rush Street Interactive closed at $9.85.</li>
<li>With a Buy rating, Gordon Haskett initiated coverage on DoorDash Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DASH#NYSE">DASH</a>). The price target seems to have been set at $206.00 for DoorDash. DoorDash earned $0.34 in the first quarter. The stock has a 52-week-high of $256.09 and a 52-week-low of $110.13. At the end of the last trading period, DoorDash closed at $174.29.</li>
<li>With a Buy rating, Gordon Haskett initiated coverage on Uber Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>). The price target seems to have been set at $65.00 for Uber Technologies. In the first quarter, Uber Technologies showed an EPS of $0.06, compared to $0.64 from the year-ago quarter. The stock has a 52-week-high of $64.05 and a 52-week-low of $28.48. At the end of the last trading period, Uber Technologies closed at $43.46.</li>
<li>Gordon Haskett initiated coverage on Lyft Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) with a Hold rating. The price target for Lyft is set to $59.00. Lyft earned $0.35 in the first quarter, compared to $0.32 in the year-ago quarter. At the moment, the stock has a 52-week-high of $68.28 and a 52-week-low of $21.34. Lyft closed at $55.32 at the end of the last trading period.</li>
<li>With a Neutral rating, Baird initiated coverage on Marketwise Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MKTW#NASDAQ">MKTW</a>). The price target seems to have been set at $16.00 for Marketwise. The stock has a 52-week-high of Missing 52-Week High and a 52-week-low of Missing 52-Week Low . At the end of the last trading period, Marketwise closed at $14.07.</li>
<li>With a Buy rating, Guggenheim initiated coverage on PMV Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMVP#NASDAQ">PMVP</a>). The price target seems to have been set at $56.00 for PMV Pharmaceuticals. Interestingly, in the first quarter, PMV Pharmaceuticals&#39;s EPS was $0.26. The stock has a 52-week-high of $63.22 and a 52-week-low of $26.38. At the end of the last trading period, PMV Pharmaceuticals closed at $34.01.</li>
<li>William Blair initiated coverage on Kura Sushi USA Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRUS#NASDAQ">KRUS</a>) with an Outperform rating. For the third quarter, Kura Sushi USA had an EPS of $0.54, compared to year-ago quarter EPS of $1.26. The stock has a 52-week-high of $56.98 and a 52-week-low of $10.00. At the end of the last trading period, Kura Sushi USA closed at $48.62.</li>
<li>With an Outperform rating, Evercore ISI Group initiated coverage on Magnolia Oil &amp; Gas Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGY#NYSE">MGY</a>). The price target seems to have been set at $18.00 for Magnolia Oil &amp; Gas. For the second quarter, Magnolia Oil &amp; Gas had an EPS of No EPS Value , compared to year-ago quarter EPS of $0.08. The stock has a 52-week-high of $16.38 and a 52-week-low of $4.09. At the end of the last trading period, Magnolia Oil &amp; Gas closed at $14.00.</li>
<li>With a Buy rating, Stifel initiated coverage on Levi Strauss &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEVI#NYSE">LEVI</a>). The price target seems to have been set at $38.00 for Levi Strauss. For the second quarter, Levi Strauss had an EPS of $0.23, compared to year-ago quarter EPS of $0.48. At the moment, the stock has a 52-week-high of $30.84 and a 52-week-low of $11.91. Levi Strauss closed at $27.52 at the end of the last trading period.</li>
<li>Credit Suisse initiated coverage on Cano Health Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANO#NYSE">CANO</a>) with an Outperform rating. The price target for Cano Health is set to $18.00. The current stock performance of Cano Health shows a 52-week-high of $16.17 and a 52-week-low of $9.53. Moreover, at the end of the last trading period, the closing price was at $10.75.</li>
<li>Goldman Sachs initiated coverage on ChargePoint Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHPT#NYSE">CHPT</a>) with a Neutral rating. The price target for ChargePoint Holdings is set to $24.00. ChargePoint Holdings earned $0.17 in the first quarter. The current stock performance of ChargePoint Holdings shows a 52-week-high of $36.86 and a 52-week-low of $19.04. Moreover, at the end of the last trading period, the closing price was at $23.65.</li>
<li>With a Buy rating, B. Riley Securities initiated coverage on Byrna Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BYRN#NASDAQ">BYRN</a>). The price target seems to have been set at $31.00 for Byrna Technologies. Interestingly, in the second quarter, Byrna Technologies&#39;s EPS was $0.16. The current stock performance of Byrna Technologies shows a 52-week-high of $27.27 and a 52-week-low of $1.25. Moreover, at the end of the last trading period, the closing price was at $24.00.</li>
<li>Keybanc initiated coverage on Rapid7 Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with an Overweight rating. The price target for Rapid7 is set to $135.00. For the first quarter, Rapid7 had an EPS of $0.03, compared to year-ago quarter EPS of $0.09. The stock has a 52-week-high of $117.12 and a 52-week-low of $56.02. At the end of the last trading period, Rapid7 closed at $113.75.</li>
</ul>
<a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">See all analyst ratings initiations.</a>

Upgrades

Downgrades

Initiation

Analyst Ratings

AVTR

BCPC

BLMN

BYRN

CANO

CHPT

CNSL

CPRI

DASH

DOMA

EBKDY

FMTX

FNCNF

FSLR

GSKY

ILIAY

INFI

KRUS

LBRT

LEVI

LYFT

MKTW

MSON

MTUAY

PMVP

RNSDF

SCPL

SCRYY

SMFKY

TDOC

TUIFY

UBER

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2021

UBS upgrades SCOR (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SCRYY#OTC">SCRYY</a>) from Sell to Neutral.

Comments

SCOR

SCOR (SCRYY) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga